JACC: Advances, 2023 Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease Prescott E., Bove K., Bechsgaard D. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
International Journal of Molecular Sciences, 2023 Does the Use of the “Proseek® Multiplex Inflammation I Panel” Demonstrate a Difference in Local and Systemic Immune Responses in Endometriosis Patients with or without Deep-Infiltrating Lesions? Perricos A., Husslein H., Kuessel L. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasmaPeritoneal Fluid | | | | |
Molecular Medicine Reports, 2023 Apolipoprotein E mimetic peptide COG1410 alleviates blood‑brain barrier injury in a rat model of ischemic stroke Xue Y., Gu M., Chen C. et al. Olink Target 96 MouseCVDNeurologyPathophysiologySerum | | | | |
Ocular Immunology and Inflammation, 2023 Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile Achten R., van Luijk C., Thijs J. et al. Olink Target 96OphthalmologyDermatological DiseasesPathophysiologyAqueous Humor | | | | |
eBioMedicine, 2023 Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis Bakhshi H., Michelhaugh S., Bruce S. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Molecular Medicine, 2023 Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning Patel M., Knauer M., Nicholson M. et al. Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma | | | | |
Alzheimer's & Dementia, 2023 Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology Wolzak K., Vermunt L., Campo M. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
Respiratory Research, 2023 Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia Palma Medina L., Babačić H., Dzidic M. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Nature Metabolism, 2023 Proteogenomic mapping sets stage for precision medicine Coral D., Franks P. Olink Explore 3072/384Wider Proteomics StudiesReview/editorial | | | | |
Nature Metabolism, 2023 Proteogenomic links to human metabolic diseases Koprulu M., Carrasco-Zanini J., Wheeler E. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum | | | | |
Nature Communications, 2023 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial Othonos N., Pofi R., Arvaniti A. et al. Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Journal of Allergy and Clinical Immunology, 2023 Proteomic and transcriptomic screening demonstrates increased mast cell–derived CCL23 in systemic mastocytosis Söderlund S., Boey D., van Midden W. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Gut Microbes, 2023 Randomized controlled trial demonstrates response to a probiotic intervention for metabolic syndrome that may correspond to diet Wastyk H., Perelman D., Topf M. et al. Olink Target 96Metabolic DiseasesNutritional SciencePathophysiologyPlasma | | | | |
Inflammation Research, 2023 Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis Dong H., Zhang L., Li B. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma | | | | |
BJU International, 2023 Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma Daza J., Salomé B., Okhawere K. et al. Olink Target 96OncologyPatient StratificationPlasmaUrine | | | | |
Frontiers in Genetics, 2023 Circulatory proteins relate cardiovascular disease to cognitive performance: A mendelian randomisation study Huang J., Gill D., Zuber V. et al. Olink Target 96CVDNeurologyPathophysiologyPlasma | | | | |
Gut, 2023 Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis Leibovitzh H., Lee S., Raygoza Garay J. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Journal of Nanobiotechnology, 2023 Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment Cano A., Esteban-de-Antonio E., Bernuz M. et al. Olink Target 96NeurologyPatient StratificationPlasmaEV LysateCSF | | | | |
Obesity Medicine, 2023 Biomarker screening in children and adolescents reveals that CUB domain-containing protein 1 is associated with obesity and that hepatocyte growth factor is associated with weight gain Manell H., Shen Q., Chowdhury A. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2023 A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes Diaz-Canestro C., Chen J., Liu Y. et al. Olink Explore 3072/384Metabolic DiseasesPathophysiologyPatient StratificationSerum | | | | |